KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

LifeMD (LFMD) Revenue (2016 - 2025)

LifeMD (LFMD) has disclosed Revenue for 14 consecutive years, with $7.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Revenue rose 4.96% year-over-year to $7.1 million, compared with a TTM value of $194.1 million through Dec 2025, up 25.34%, and an annual FY2025 reading of $194.1 million, up 25.34% over the prior year.
  • Revenue was $7.1 million for Q4 2025 at LifeMD, down from $60.2 million in the prior quarter.
  • Across five years, Revenue topped out at $75.9 million in Q2 2025 and bottomed at $6.7 million in Q4 2024.
  • Average Revenue over 5 years is $35.7 million, with a median of $32.3 million recorded in 2022.
  • The sharpest move saw Revenue soared 322.74% in 2021, then crashed 84.96% in 2024.
  • Year by year, Revenue stood at $27.4 million in 2021, then rose by 2.56% to $28.1 million in 2022, then soared by 59.53% to $44.9 million in 2023, then plummeted by 84.96% to $6.7 million in 2024, then grew by 4.96% to $7.1 million in 2025.
  • Business Quant data shows Revenue for LFMD at $7.1 million in Q4 2025, $60.2 million in Q3 2025, and $75.9 million in Q2 2025.